A
Alkermes Public · 1,001–5,000 employees
Biotech & PharmaHealthcare & Health Tech
Alkermes is a global biopharmaceutical company that researches, develops, manufactures, and commercializes medicines for complex neurological and psychiatric disorders. Its portfolio includes treatments for alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder, and narcolepsy.